description
CONTENT: Tamoxiver, 20mg 25 pills
Tamoxiver used by athletes to combat high levels of estradiol when using AAS. Learn more about the properties of the drug and how it is used.
The mechanism of operation for Tamoxifera is the inhibition of estrogen receptors. So far, scientists have been confident that TAMOXIVER has no anti-estrogenic properties, but over the course of research this theory has been refuted. Because of this, the drug is widely used by athletes. Also, the popularity of the preparation in many respects is determined by the low price.
Many anabolic steroids have the ability to interact with a special enzyme called aromatase. Under its influence, testosterone is converted into estradiol, which leads to an increase in the concentration of the latter. This is the reason for the manifestation of a sufficiently large number of side effects. It is to combat that TAMOXIVER is used.
Effects and benefits
According to tamoxifen reviews, the drug has the following benefits:
• Restoring testosterone levels.
• Improves the hormonal background.
• Carries out estrogens.
• Stimulates the internal secretion organs and allows the restoration of the natural production of male androgens.
• reduces cholesterol.
• Increases the amount of globulin.
Dosages of Tamoxifen
Dependent From the combination of steroids on the course, tamoxifen cannot be the same. The athlete's experience plays an important role here. Tamoxifen, unlike the popular Clomid preparation, is more pronounced. Most often enough 20 milligrams of the drug to prevent gynecomastia and other side effects. In this case the dose is in two Cans divided – 10 mg in the morning and the same in the evening. Tamoxifen is great for anabolic methane-based courses. The same goes for turinabol and other steroids. It is necessary to choose the correct dosage so that there are no side effects. The working dosage of a very popular agent with anti-estrogenic properties, namely Tamoxiver, is 10 to 30 milligrams per day. If there is a tendency towards flavoring, the daily dose is 20 – 30 mg . Tablets are taken with food.
Side effects
Tamoxiver in the treatment of the most common side effects related to its antiestrogenic effects, which take the form of hot flashes (hot flashes), vaginal bleeding or discharge, genital itching, alopecia, pain in the area of the lesion, ossalgiya, weight gain. Less common or rarely observed side effects included: fluid retention, anorexia, nausea, vomiting, constipation, fatigue, depression, confusion, headache, dizziness , Drowsiness, fever, rash, blurred vision, including Corneal changes , Cataracts, retinopathy and optic neuritis. At the beginning of treatment, exacerbation can be local - to increase the size of soft tissue structures, sometimes accompanied by severe erythema, Lesions and surrounding areas - which usually go away within 2 weeks. May increase the risk of thrombosis and thrombophlebitis. Sometimes there may be transient leukopenia and thrombocytopenia and increased liver dysfunction such as fatty liver, cholestasis and hepatitis. Hypercalcaemia has been observed in some patients with baseline bone metastases. Tamoxiver causes amenorrhea or irregular onset of menstruation in women in the premenopausal and reversible development of cystic ovarian tumors. With long-term treatment with tamoxifen citrate, changes in the endometrium may occur, including hyperplasia, polyps, and in rare cases - cancer of the endometrium and the development of Uterusmyomen . May increase the risk of thrombosis and thrombophlebitis. Sometimes there may be transient leukopenia and thrombocytopenia and increased liver dysfunction such as fatty liver, cholestasis and hepatitis. Hypercalcaemia has been observed in some patients with baseline bone metastases. Tamoxiver causes amenorrhea or irregular onset of menstruation in women in the premenopausal and reversible development of cystic ovarian tumors. With long-term treatment with tamoxifen citrate, changes in the endometrium may occur, including hyperplasia, polyps, and in rare cases - cancer of the endometrium and the development of Uterusmyomen . May increase the risk of thrombosis and thrombophlebitis. Sometimes there may be transient leukopenia and thrombocytopenia and increased liver dysfunction such as fatty liver, cholestasis and hepatitis. Hypercalcaemia has been observed in some patients with baseline bone metastases. Tamoxiver causes amenorrhea or irregular onset of menstruation in women in the premenopausal and reversible development of cystic ovarian tumors. With long-term treatment with tamoxifen citrate, changes in the endometrium may occur, including hyperplasia, polyps, and in rare cases - cancer of the endometrium and the development of Uterusmyomen . As well as increased liver dysfunction such as fatty liver, cholestasis and hepatitis. Hypercalcaemia has been observed in some patients with baseline bone metastases. Tamoxiver causes amenorrhea or irregular onset of menstruation in women in the premenopausal and reversible development of cystic ovarian tumors. With long-term treatment with tamoxifen citrate, changes in the endometrium may occur, including hyperplasia, polyps, and in rare cases - cancer of the endometrium and the development of Uterusmyomen . As well as increased liver dysfunction such as fatty liver, cholestasis and hepatitis. Hypercalcaemia has been observed in some patients with baseline bone metastases. Tamoxiver causes amenorrhea or irregular onset of menstruation in women in the premenopausal and reversible development of cystic ovarian tumors. With long-term treatment with tamoxifen citrate, changes in the endometrium may occur, including hyperplasia, polyps, and in rare cases - cancer of the endometrium and the development of Uterusmyomen . Tamoxiver causes amenorrhea or irregular onset of menstruation in women in the premenopausal and reversible development of cystic ovarian tumors. With long-term treatment with tamoxifen citrate, changes in the endometrium may occur, including hyperplasia, polyps, and in rare cases - cancer of the endometrium and the development of Uterusmyomen . Tamoxiver causes amenorrhea or irregular onset of menstruation in women in the premenopausal and reversible development of cystic ovarian tumors. With long-term treatment with tamoxifen citrate, changes in the endometrium may occur, including hyperplasia, polyps, and in rare cases - cancer of the endometrium and the development of Uterusmyomen .
